Emerging evidence suggests SARS-CoV-2 infection may exacerbate psoriasis, supported by elevated plasma inflammatory cytokines (e.g., granulocyte-colony stimulating factor, tumor necrosis factor-alpha) correlating with disease severity (55, 56). The gene discussed is TNF; the disease is psoriasis.